In the United States, digestive diseases remain a significant cause of mortality, according to an analysis of multiple national databases.

While sleep supplements can be beneficial, the lack of regulation means consumers are not assured of a safe and effective product.

In a recent clinical guideline, recommendations are presented for the diagnosis and management of eosinophilic esophagitis.

A recent study finds that physiological metrics from wearable devices can help identify inflammatory bowel disease flares.

The majority of patients with postacute sequelae of COVID-19/post-COVID-19 syndrome do not recover in the second year of their illness.

For young individuals with cancer, residence in redlined neighborhoods is associated with lower survival at five and 10 years.

The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via PEPFAR.

A new strain of bird flu, H5N9, has been detected for the first time in the United States, raising concerns about how it continues to spread.

For patients diagnosed with cancer, high muscle strength and cardiorespiratory fitness associated with reduced risk for all-cause mortality.

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes.

Staff at the U.S. Centers for Disease Control and Prevention have been told to stop communication with the World Health Organization.

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.